Who are Regeneron Pharmaceuticals's board members?

Kathryn Guarini (since September 8, 2023) and David P. Schenkein (since September 8, 2023), as the record asserts them on November 13, 2026.

organization · fact

Regeneron Pharmaceuticals board members

As of November 13, 2026, Regeneron Pharmaceuticals's board members on the AsOf record are Kathryn Guarini and David P. Schenkein, each a claim of its own with its date, from 1 source in all.

Regeneron Pharmaceuticals on another date · compare two dates

board members: Kathryn GuariniSeptember 8, 2023 · 1 source
board members: David P. SchenkeinSeptember 8, 2023 · 1 source

Each bar is one value's span on the record; the open one in colour.

Every dated value

2 values · 2 current

Regeneron Pharmaceuticals board members: every dated value on the record, oldest first, with its dates, status, confidence and sources
value	valid fromThe day the value took effect, not the day it was published. A period figure (a year's revenue) is dated at the period's end.More in About →	valid to	confidenceHow well the sources support the value, from 0 to 1. A single primary source is asserted from 0.7; nothing below 0.5 is asserted; a dead or disagreeing source lowers it.More in About →	sourcesPrimary: the entity's own filing, feed or site. Secondary: a publisher reporting it. Each claim links every source it has, with the passage that states the value where one was read.More in About →
Kathryn Guarini: board members Kathryn Guarini from 2023-09-08, claim clm_56C3CBA1B61B and its sources to present · sec.gov	2023-09-08	present	0.95	sec.gov
David P. Schenkein: board members David P. Schenkein from 2023-09-08, claim clm_CE05B7C86D54 and its sources to present · sec.gov	2023-09-08	present	0.95	sec.gov

Questions this record answers

Who are Regeneron Pharmaceuticals's board members?: Kathryn Guarini (since September 8, 2023) and David P. Schenkein (since September 8, 2023), as the record asserts them on November 13, 2026.

Answered from the rows above, as of November 13, 2026.

Cite Regeneron Pharmaceuticals board members

Each form names the value, its as-of date (2023-09-08), the day you read it (2026-11-13), the claim's stable URL and id and its primary source. The URL never changes: a superseded claim stays at the same address.

Plain text

AsOf. "Regeneron Pharmaceuticals board member: Kathryn Guarini", as of 2023-09-08. Claim clm_56C3CBA1B61B, https://asof.is/claim/clm_56C3CBA1B61B, accessed 2026-11-13. Source: https://www.sec.gov/Archives/edgar/data/872589/000110465923099345/0001104659-23-099345-index.htm.

APA

AsOf. (2023). Regeneron Pharmaceuticals board member: Kathryn Guarini (as of 2023-09-08) [Record clm_56C3CBA1B61B]. Retrieved November 13, 2026, from https://asof.is/claim/clm_56C3CBA1B61B (source: https://www.sec.gov/Archives/edgar/data/872589/000110465923099345/0001104659-23-099345-index.htm)

BibTeX

@misc{asof_clm_56C3CBA1B61B,
  author = {AsOf},
  title = {Regeneron Pharmaceuticals board member: Kathryn Guarini},
  year = {2023},
  howpublished = {\url{https://asof.is/claim/clm_56C3CBA1B61B}},
  note = {Claim clm\_56C3CBA1B61B, as of 2023-09-08; source: https://www.sec.gov/Archives/edgar/data/872589/000110465923099345/0001104659-23-099345-index.htm},
  urldate = {2026-11-13}
}

Read on

/record/regeneron-pharmaceuticals/board_member.md · this page as markdown
/facts/board_member · every company's board members
/record/regeneron-pharmaceuticals · /timelines/regeneron-pharmaceuticals

Other facts about Regeneron Pharmaceuticals

Record